Mobile elements comprise about half of the human genome. Three active mobile element families (L1, Alu, and SVA) possibly cause diseases such as cancer. We conducted mobile element insertion (MEI) profiling of 44 epithelial ovarian cancers using exomesequencing data. We identified a total of 106 MEIs using the Mobster program, 8 of which were novel exonic MEIs.
MEI detection was conducted using Mobster with the default setting. 6 To manually review MEIs, MEIs with split read(s) were maintained. Mobster detected a total of 106 (29 L1 and 77 Alu) MEIs with split reads from the 44 ovarian cancer samples (Supplementary Information 3). We extracted exonic MEIs using bedtools. 8 Then, the regions previously reported as polymorphisms 5, 6, 9, 10 with allelic fractions o 0.005 (the number of split reads supporting MEI/the number of total reads spanning the insertion point) were removed. 5 Finally, eight exonic MEIs (3 L1 and 5 Alu) were identified as novel (Table 1) . For the eight MEIs on eight genes (OTUD7B, PDLIM7, RP1, XKR9, SLC30A8, KIFC2, OR1L4, and IPO4), we manually reviewed the insertion points and zygosity with split reads by IGV (Figure 1a) . We further performed PCR and were able to validate the existence of MEIs in seven of the eight genes (Table 1 and Supplementary Information 1). All seven MEIs were assumed to be heterozygous. Five of the seven MEIs were assumed to be somatic by comparison with matched normal data ( Figure 1a and Supplementary Information 1). However, two of the five assumed somatic MEIs were also detected as germline MEIs in matched normal samples by PCR. These false MEI detections by Mobster in normal samples could be caused by insufficient sensitivity with low coverage of reads. When simulated exome data are used with homozygous MEIs, the sensitivity of Mobster is limited to the range from 52.7 to 85.4% at a depth of 10 × to 160 × , respectively. 6 The mean depth of our exome-sequencing data was 112 × , ranging from 68 × to 166 × . For five of the seven MEIs, ME subfamilies were predicted using clipped sequences (Figure 1b ) by CENSOR. 11 One ME (L1HS) belongs to an active subfamily, whereas the other four MEs (4 AluS) are members of ancient, inactive subfamilies. [12] [13] [14] Insertions of these ancient ME subfamilies may not occur through the canonical mechanism of target-primed reverse transcription, 3 but they can occur through genomic rearrangement, including chromosomal translocation. 15 In this study, we detected 106 MEIs from split reads of 44 samples (average 2.4, range 0-8 per sample). Fewer MEIs were detected compared with CEU trio's exome data set (average 7.3, range 6-8 per sample). 6 These results may suggest that some parameter adjustments of Mobster are required to detect more MEIs from the exome-sequencing data.
We found three novel somatic exonic MEIs for three genes (PDLIM7, SLC30A8, and IPO4) in ovarian cancer patients. Somatic exonic MEIs are rare events in cancer and have not previously been reported for ovarian cancer in previous studies.
5,10 PDLIM7, also known as LIM mineralization protein-1 (LMP-1), was reported to be a tumor suppressor in osteosarcoma cells. 16 IPO4, also known as Importin 4, has a role in the nuclear import of FANCD2, which is associated with tumor suppression. 17 Disruptions of PDLIM7 and IPO4 may be associated with ovarian cancer malignancy and a deficiency in a tumor-suppressing mechanism, respectively. A nonsense mutation in SLC30A8 was found in nontriple-negative breast cancer. 18 We found four germline exonic MEIs in four genes (OTUD7B, RP1, XKR9, and KIFC2). OTUD7B was reported to control the non-canonical NF-kB pathway, the activation of which is important for cell growth and survival.
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XKR9 enhanced apoptosis by promoting phosphatidylserine exposure. 20 Disruption of OTUD7B and XKR9 would be advantageous to ovarian cancer cell growth and survival. The functional relevance of RP1 and KIFC2 to cancer has not yet been reported. Further studies are required to investigate the functional significance of these gene products for ovarian cancer. We were not able to detect an MEI for OR1L4 by PCR. The relatively low allelic fraction of this MEI (Supplementary Information 4) suggests that it is a false positive.
In conclusion, we identified 106 MEIs from 44 ovarian cancer samples, including 8 novel exonic MEIs. PCR validation demonstrated a high specificity of exonic MEI detection (87.5%, 7/8). This is the first report of MEI detection in ovarian cancer using exomesequencing data. This approach will provide new insights for studies of cancer-causing mutations. 
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